About DBpedia About UPM

About: Glucoproteína 130

An Entity of Type : Thing, from Named Graph : http://es.dbpedia.org, within Data Space : es.dbpedia.org

La glucoproteína 130 (también conocida como gp130, IL6ST, IL6-beta o CD130) es una proteína transmembrana y el miembro fundador de la clase de los receptores de citoquinas. Es una subunidad proteica del dentro de la familia de Receptor de receptores IL-6. A menudo se le conoce como la subunidad gp130 común, y es importante para la transducción de señales después del acoplamiento de citoquinas.

Property Value
dbo:abstract
  • La glucoproteína 130 (también conocida como gp130, IL6ST, IL6-beta o CD130) es una proteína transmembrana y el miembro fundador de la clase de los receptores de citoquinas. Es una subunidad proteica del dentro de la familia de Receptor de receptores IL-6. A menudo se le conoce como la subunidad gp130 común, y es importante para la transducción de señales después del acoplamiento de citoquinas. (es)
  • La glucoproteína 130 (también conocida como gp130, IL6ST, IL6-beta o CD130) es una proteína transmembrana y el miembro fundador de la clase de los receptores de citoquinas. Es una subunidad proteica del dentro de la familia de Receptor de receptores IL-6. A menudo se le conoce como la subunidad gp130 común, y es importante para la transducción de señales después del acoplamiento de citoquinas. (es)
dbo:wikiPageID
  • 8898991 (xsd:integer)
dbo:wikiPageLength
  • 15587 (xsd:integer)
dbo:wikiPageRevisionID
  • 120186369 (xsd:integer)
prop-es:authors
  • Diamant M, Rieneck K, Mechti N, Zhang XG, Svenson M, Bendtzen K, Klein B (es)
  • Lee IS, Liu Y, Narazaki M, Hibi M, Kishimoto T, Taga T (es)
  • Rodriguez C, Grosgeorge J, Nguyen VC, Gaudray P, Theillet C (es)
  • Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (es)
  • Barton VA, Hudson KR, Heath JK (es)
  • Bravo J, Staunton D, Heath JK, Jones EY (es)
  • Chung TD, Yu JJ, Kong TA, Spiotto MT, Lin JM (es)
  • Kim H, Baumann H (es)
  • Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ (es)
  • Schiemann WP, Bartoe JL, Nathanson NM (es)
  • Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (es)
  • Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D (es)
  • Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T (es)
  • Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S, Smith SK (es)
  • Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR (es)
  • Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD (es)
  • Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T (es)
  • Tacken I, Dahmen H, Boisteau O, Minvielle S, Jacques Y, Grötzinger J, Küster A, Horsten U, Blanc C, Montero-Julian FA, Heinrich PC, Müller-Newen G (es)
  • Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J, Müller W, Chien KR (es)
  • Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A, Gascan H (es)
  • Diamant M, Rieneck K, Mechti N, Zhang XG, Svenson M, Bendtzen K, Klein B (es)
  • Lee IS, Liu Y, Narazaki M, Hibi M, Kishimoto T, Taga T (es)
  • Rodriguez C, Grosgeorge J, Nguyen VC, Gaudray P, Theillet C (es)
  • Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (es)
  • Barton VA, Hudson KR, Heath JK (es)
  • Bravo J, Staunton D, Heath JK, Jones EY (es)
  • Chung TD, Yu JJ, Kong TA, Spiotto MT, Lin JM (es)
  • Kim H, Baumann H (es)
  • Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ (es)
  • Schiemann WP, Bartoe JL, Nathanson NM (es)
  • Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (es)
  • Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D (es)
  • Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T (es)
  • Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S, Smith SK (es)
  • Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR (es)
  • Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD (es)
  • Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T (es)
  • Tacken I, Dahmen H, Boisteau O, Minvielle S, Jacques Y, Grötzinger J, Küster A, Horsten U, Blanc C, Montero-Julian FA, Heinrich PC, Müller-Newen G (es)
  • Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J, Müller W, Chien KR (es)
  • Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A, Gascan H (es)
prop-es:doi
  • 101002 (xsd:integer)
  • 101016 (xsd:integer)
  • 101046 (xsd:integer)
  • 101074 (xsd:integer)
  • 101093 (xsd:integer)
  • 101095 (xsd:integer)
  • 101126 (xsd:integer)
  • 101159 (xsd:integer)
prop-es:issue
  • 1 (xsd:integer)
  • 2 (xsd:integer)
  • 3 (xsd:integer)
  • 4 (xsd:integer)
  • 6 (xsd:integer)
  • 7 (xsd:integer)
  • 9 (xsd:integer)
  • 25 (xsd:integer)
  • 26 (xsd:integer)
  • 45 (xsd:integer)
  • 49 (xsd:integer)
  • 51 (xsd:integer)
  • 5115 (xsd:integer)
prop-es:journal
  • J. Biol. Chem. (es)
  • Cell (es)
  • Science (es)
  • Blood (es)
  • Eur. J. Biochem. (es)
  • FEBS Lett. (es)
  • Biol. Reprod. (es)
  • EMBO J. (es)
  • Cytogenet. Cell Genet. (es)
  • Prostate (es)
  • J. Biol. Chem. (es)
  • Cell (es)
  • Science (es)
  • Blood (es)
  • Eur. J. Biochem. (es)
  • FEBS Lett. (es)
  • Biol. Reprod. (es)
  • EMBO J. (es)
  • Cytogenet. Cell Genet. (es)
  • Prostate (es)
prop-es:pages
  • 1 (xsd:integer)
  • 64 (xsd:integer)
  • 133 (xsd:integer)
  • 189 (xsd:integer)
  • 379 (xsd:integer)
  • 573 (xsd:integer)
  • 645 (xsd:integer)
  • 974 (xsd:integer)
  • 1120 (xsd:integer)
  • 1121 (xsd:integer)
  • 1149 (xsd:integer)
  • 1665 (xsd:integer)
  • 1805 (xsd:integer)
  • 1808 (xsd:integer)
  • 5755 (xsd:integer)
  • 15760 (xsd:integer)
  • 16631 (xsd:integer)
  • 28563 (xsd:integer)
  • 30741 (xsd:integer)
  • 32635 (xsd:integer)
prop-es:pmc
  • 1170514 (xsd:integer)
prop-es:pmid
  • 1617725 (xsd:integer)
  • 2261637 (xsd:integer)
  • 2788034 (xsd:integer)
  • 7736792 (xsd:integer)
  • 8353278 (xsd:integer)
  • 8390097 (xsd:integer)
  • 8511589 (xsd:integer)
  • 8547494 (xsd:integer)
  • 8999038 (xsd:integer)
  • 9013873 (xsd:integer)
  • 9188471 (xsd:integer)
  • 9195977 (xsd:integer)
  • 9256256 (xsd:integer)
  • 9353320 (xsd:integer)
  • 9388212 (xsd:integer)
  • 9501088 (xsd:integer)
  • 10026196 (xsd:integer)
  • 10219240 (xsd:integer)
  • 10504396 (xsd:integer)
  • 10579793 (xsd:integer)
prop-es:title
  • Dual oncostatin M receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation (es)
  • Identification of three distinct receptor binding sites of murine interleukin-11 (es)
  • Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130 (es)
  • Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos (es)
  • Crystal structure of a cytokine-binding region of gp130 (es)
  • Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells (es)
  • Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598 (es)
  • Human gp130 transducer chain gene is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11 (es)
  • Signaling of type II oncostatin M receptor (es)
  • CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 (es)
  • Molecular cloning and expression of an IL-6 signal transducer, gp130 (es)
  • LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor (es)
  • Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines (es)
  • Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis (es)
  • Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress (es)
  • Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6 (es)
  • Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 (es)
  • IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase (es)
  • Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras (es)
  • Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130 (es)
  • Dual oncostatin M receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation (es)
  • Identification of three distinct receptor binding sites of murine interleukin-11 (es)
  • Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130 (es)
  • Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos (es)
  • Crystal structure of a cytokine-binding region of gp130 (es)
  • Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells (es)
  • Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598 (es)
  • Human gp130 transducer chain gene is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11 (es)
  • Signaling of type II oncostatin M receptor (es)
  • CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 (es)
  • Molecular cloning and expression of an IL-6 signal transducer, gp130 (es)
  • LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor (es)
  • Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines (es)
  • Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis (es)
  • Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress (es)
  • Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6 (es)
  • Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 (es)
  • IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase (es)
  • Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras (es)
  • Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130 (es)
prop-es:volume
  • 17 (xsd:integer)
  • 42 (xsd:integer)
  • 53 (xsd:integer)
  • 58 (xsd:integer)
  • 63 (xsd:integer)
  • 69 (xsd:integer)
  • 70 (xsd:integer)
  • 82 (xsd:integer)
  • 97 (xsd:integer)
  • 260 (xsd:integer)
  • 265 (xsd:integer)
  • 271 (xsd:integer)
  • 272 (xsd:integer)
  • 274 (xsd:integer)
  • 401 (xsd:integer)
  • 412 (xsd:integer)
prop-es:year
  • 1989 (xsd:integer)
  • 1991 (xsd:integer)
  • 1992 (xsd:integer)
  • 1993 (xsd:integer)
  • 1995 (xsd:integer)
  • 1996 (xsd:integer)
  • 1997 (xsd:integer)
  • 1998 (xsd:integer)
  • 1999 (xsd:integer)
  • 2000 (xsd:integer)
dct:subject
rdfs:comment
  • La glucoproteína 130 (también conocida como gp130, IL6ST, IL6-beta o CD130) es una proteína transmembrana y el miembro fundador de la clase de los receptores de citoquinas. Es una subunidad proteica del dentro de la familia de Receptor de receptores IL-6. A menudo se le conoce como la subunidad gp130 común, y es importante para la transducción de señales después del acoplamiento de citoquinas. (es)
  • La glucoproteína 130 (también conocida como gp130, IL6ST, IL6-beta o CD130) es una proteína transmembrana y el miembro fundador de la clase de los receptores de citoquinas. Es una subunidad proteica del dentro de la familia de Receptor de receptores IL-6. A menudo se le conoce como la subunidad gp130 común, y es importante para la transducción de señales después del acoplamiento de citoquinas. (es)
rdfs:label
  • Glucoproteína 130 (es)
  • Glucoproteína 130 (es)
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is owl:sameAs of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License